Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate in Asian PTCL Patients
NCT03150602Phase 4Unknown
- Sponsor
- Mundipharma
- Start
- Aug 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pralatrexate in peripheral T-cell lymphoma (PTCL), sponsored by Mundipharma. Status: unknown.
02
Drugs
pralatrexate
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03150602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150602.